Amryt Pharma

Showing 3 posts of 3 posts found.

NICE approves lipid disorder drug Myalepta for NHS use

January 20, 2021
Research and Development Amryt Pharma, NICE

NICE has approved Amryt’s rare lipid disorder drug Myalepta (metreleptin), currently the only leptin replacement therapy available, for use within …

Working Life: Joe Wiley, CEO, Amryt Pharma

October 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, CEO, Ireland, Joe WIley, pharma

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …

12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

Latest content